BMO Capital Markets analyst Evan Seigerman discusses the Trump Administration's deal with Big Pharma. Plus, meet the Suspicious 8, with 6% dividends and lots of problems.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
32:27
--------
32:27
Bull Market Health Check. Plus, Philip Morris CEO Jacek Olczak
A top Wall Street strategist discusses A.I. and stock valuations. And Big Tobacco talks smokefree profits.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
34:14
--------
34:14
Nuclear Power’s Bright Outlook. Plus, Quarterly Or Semiannual Reporting?
A top Wall Street strategist talks fission (and fusion). And Jack has a guide to arguing about company reporting.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
34:08
--------
34:08
Worldcoin's 3000% Gain. Plus, Gold, Dividends and Wedgification.
Crypto treasuries are dominating. Gold is up. Jack explains why, and answers listener questions on dividends.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
27:37
--------
27:37
Dividends for A Pricey Market
Is the stock market too expensive? Jack compares two perspectives. Plus, the deal on dividends.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Get the lowdown on high finance each week with Barron’s columnist Jack Hough. Business leaders and trendspotters, insights and absurdities—this is Wall Street like you've never heard before.
Italia